Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, Marcin, Berger, Alice H., Hammerman, Peter S., Hernandez, Bryan, Pugh, Trevor J., Hodis, Eran, Cho, Jeonghee, Suh, James +37 more·2012·Cell
DOI 10.1016/j.cell.2012.08.029

Cited by (1,000)

Items 701–800 of 1,000

  1. Exome sequencing identifies frequent mutation of MLL2 in non–small cell lung carcinoma from Chinese patients
    Shanye Yin, Jing Yang, Bin Lin, Wenjun Deng, Yuchao Zhang, Xianfu Yi, Yufang Shi, Yong Tao, Jun Cai, Chung‐I Wu et al. · 2014 · Scientific Reports
  2. Molecular biosensors: promising new tools for early detection of cancer
    Ibtisam E. Tothill, Zeynep Altıntaş · 2015 · Nanobiosensors in Disease Diagnosis
  3. Biomarkers and Molecular Testing for Early Detection, Diagnosis, and Therapeutic Prediction of Lung Cancer
    Harvey Ira Pass, David G. Beer, Sasha O Joseph, Pierre P. Massion · 2013 · Thoracic surgery clinics/Thorac. surg. clin.
  4. A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation
    María Sereno, Víctor Moreno, Juan Moreno‐Rubio, César Gómez-Raposo, Sagrario García Sánchez, Rebeca Hernández Jusdado, Sandra Falagán, Francisco Zambrana Tévar, Enrique Casado Sáenz · 2015 · Anti-Cancer Drugs
  5. The global landscape of intron retentions in lung adenocarcinoma
    Qu Zhang, Hua Li, Hongchuan Jin, Huibiao Tan, Jun Zhang, Sitong Sheng · 2014 · BMC Medical Genomics
  6. Dynamic Interplay of Oncogenes and T Cells Induces PD-L1 in the Tumor Microenvironment
    Andrew J. Rech, Robert H. Vonderheide · 2013 · Cancer Discovery
  7. Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity.
    Sara Pilotto, Miguel Ángel Molina‐Vila, Niki Karachaliou, Luisa Carbognin, Santiago Viteri, María González‐Cao, Emilio Bria, Giampaolo Tortora, Rafael Rosell · 2015 · PubMed Central
  8. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors
    Ali Saber, T. Jeroen N. Hiltermann, Klaas Kok, Martijn M. Terpstra, Kim de Lange, Wim Timens, Harry J.M. Groen, Anke van den Berg · 2016 · Carcinogenesis
  9. RETRACTED: HOXC10 Promotes the Metastasis of Human Lung Adenocarcinoma and Indicates Poor Survival Outcome
    Xiaolei Tang, Bang-Xian Ding, Ying Hua, Hao Chen, Tao Wu, Zhangquan Chen, Chunhui Yuan · 2017 · Frontiers in Physiology · Retracted
  10. Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3
    Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, Daichi Shikata, Yujiro Yokoyama, Rumi Higuchi, Sotaro Otake, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki et al. · 2018 · Cancers
  11. More than a messenger: Alternative splicing as a therapeutic target
    Adam J. Black, Jennifer R. Gamarra, Jimena Giudice · 2019 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  12. Identification of Clonality through Genomic Profile Analysis in Multiple Lung Cancers
    Rumi Higuchi, Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, Daichi Shikata, Yujiro Yokoyama, Sotaro Otake, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki et al. · 2020 · Journal of Clinical Medicine
  13. Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non–Small Cell Lung Carcinoma
    Shujie Song, Vinh Q Nguyen, Travis Parke Schrank, Kathleen M. Mulvaney, Vonn Walter, Darmood Wei, Tess Orvis, Nisarg P. Desai, Jiren Zhang, David Neil Hayes et al. · 2020 · Molecular Cancer Research
  14. Denoising Autoencoder, A Deep Learning Algorithm, Aids the Identification of A Novel Molecular Signature of Lung Adenocarcinoma
    Jun Wang, Xueying Xie, Junchao Shi, Wenjun He, Qi Chen, Liang Chen, Wanjun Gu, Tong Zhou · 2020 · Genomics Proteomics & Bioinformatics
  15. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
    Akihide Yoshimi, Omar Ibrahim Abdel-Wahab · 2016 · Clinical Cancer Research
  16. Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations
    Qiangqiang He, Meiyu Qu, Hangyang Bao, Yana Xu, Tingyu Shen, Dan Tan, Muhammad Qasim Barkat, Chengyun Xu, Linghui Zeng, Ximei Wu · 2023 · Cytokine & Growth Factor Reviews
  17. Next-Generation Sequencing for Lung Cancer
    Kehua Wu, R. Stephanie Huang, Larry K. House, William Chi Shing Cho · 2013 · Future Oncology
  18. Tousled-Like Kinase-Dependent Phosphorylation of Rad9 Plays a Role in Cell Cycle Progression and G2/M Checkpoint Exit
    Ryan M. Kelly, Scott K. Davey · 2013 · PLoS ONE
  19. How the environment shapes cancer genomes
    Gerd P. Pfeifer · 2014 · Current Opinion in Oncology
  20. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis
    Jian Wang, Alton B. Farris, Kaiming Xu, Ping Wang, Xiangming Zhang, Duc Minh Duong, Hong Liang Yi, Hui‐Kuo G. Shu, Shi‐Yong Sun, Ya Wang · 2016 · Nature Communications
  21. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer
    Andrea Selenito Imperatori, Nora Sahnane, Nicola Rotolo, Francesca Franzi, Elisa Nardecchia, Laura Libera, Chiara Romualdi, Maria Cattoni, Fausto Sessa, Lorenzo Dominioni et al. · 2017 · Lung Cancer
  22. ZEB1-activated LINC01123 accelerates the malignancy in lung adenocarcinoma through NOTCH signaling pathway
    Miao Zhang, Yaguang Han, Yi Zheng, Yan Zhang, Xin Zhao, Zhenlin Gao, Xinyan Liu · 2020 · Cell Death and Disease
  23. Oxidative stress-mediated AMPK inactivation determines the high susceptibility of LKB1-mutant NSCLC cells to glucose starvation
    Yi Ren, Jiaqing Chen, Peishi Chen, Qi Hao, Leng-Kuan Cheong, Mingzhu Tang, Lian‐Lian Hong, Xuanyu Hu, Celestial T. Yap, Boon‐Huat Bay et al. · 2021 · Free Radical Biology and Medicine
  24. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach
    Alexander J. Neil, Lei Zhao, Raymond A. Isidro, Amitabh Srivastava, James M. Cleary, Fei Dong · 2023 · Modern Pathology
  25. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11
    Anna Zagryazhskaya, Olga V. Surova, Nadeem S. Akbar, Giulia Allavena, Katarína Gyurászová, Irina B. Zborovskaya, Elena M. Tchevkina, Boris Zhivotovsky · 2015 · Oncotarget
  26. New Insights and Challenges in Mismatch Repair: Getting Over the Chromatin Hurdle
    Guo-Min Li · 2014 · DNA Repair
  27. Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers
    Vipin Yadav, Shih-Hsun Chen, Yong Gong Yue, Sean G. Buchanan, Richard Paul Beckmann, Sheng-Bin Peng · 2014 · Pharmacology & Therapeutics
  28. Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC
    Jeremy H. Tchaicha, Esra A. Akbay, Abigail B. Altabef, Oliver R. Mikse, Eiki Kikuchi, Kevin Rhee, Rachel G. Liao, Roderick Terry Bronson, Lynette Marie Sholl, Matthew M. Meyerson et al. · 2014 · Cancer Research
  29. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma
    Xing Wei, Kun Zhang, Haifeng Qin, Jinlong Zhu, Qiaoxi Qin, Yu Pu Yang, Hong Wang · 2018 · BMC Cancer
  30. Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma
    Han-Jun Cho, Soonchul Lee, Young Geon Ji, Dong Hyeon Lee · 2018 · PLoS ONE
  31. Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling
    Ana Raquel‐Cunha, Diana Cardoso‐Carneiro, Rui Manuel Reis, Olga Martinho · 2019 · Cells
  32. Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma
    Yinan Hu, Jun Yu, Qi Wang, Lei Zhang, Xueying Chen, Yong Cao, Jianping Zhao, Yongjian Xu, Dingsheng Jiang, Yi Wang et al. · 2020 · Molecular Therapy — Oncolytics
  33. Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma
    Na Qin, Yuancheng Li, Cheng Wang, Meng Zhu, Juncheng Dai, Tongtong Hong, Demetrius Albanes, Stephen C. Lam, Adonina Tardón, Chu Chen et al. · 2020 · Frontiers of Medicine
  34. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers
    Samar Alsafadi, Stéphane Dayot, Malcy Tarin, Alexandre Houy, Dorine Bellanger, Michele Cornella, Michel Adam Wassef, Joshua J. Waterfall, Erik M Lehnert, Sergio Roman‐Roman et al. · 2020 · Oncogene
  35. Advances in Lung Cancer Driver Genes Associated With Brain Metastasis
    Yalin Kang, Yu Tong Jin, Qianxia Li, Xianglin Yuan · 2021 · Frontiers in Oncology
  36. Directional genomic hybridization for chromosomal inversion discovery and detection
    F. Andrew Ray, Erin Zimmerman, Bruce W. S. Robinson, Michael N. Cornforth, Joel S. Bedford, Edwin H. Goodwin, Susan M. Bailey · 2013 · Chromosome Research
  37. Dysregulation of mTOR activity through LKB1 inactivation
    Wei Zhou, Adam I. Marcus, Paula M. Vertino · 2013 · 癌症：英文版
  38. Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation
    Jianyong Zou, Amos Éla Bella, Zhenguang Chen, XiangQian Han, Chunhua Su, Yiyan Lei, Honghe Luo · 2014 · Journal of International Medical Research
  39. Bone Metastases in Lung Cancer. Potential Novel Approaches to Therapy
    Silvestre Vicent, Naiara Perurena, Ramaswamy Govindan, Fernando Lecanda · 2015 · American Journal of Respiratory and Critical Care Medicine
  40. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis
    Marcela Santos Cavalcanti, Anne Maria Schultheis, Caleb Ho, Lu Wang, Deborah F. DeLair, Britta Weigelt, Ginger J. Gardner, Stuart M. Lichtman, Meera Hameed, Kay J. Park · 2016 · International Journal of Gynecological Pathology
  41. Structural basis for the recognition of spliceosomal SmN/B/B’ proteins by the RBM5 OCRE domain in splicing regulation
    André Mourão, Sophie Bonnal, Komal Soni, Lisa Warner, Rémy Bordonné, Juan Valcárcel, Michael Sattler · 2016 · eLife
  42. Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
    G. Steven Bova, Heini M. L. Kallio, Matti Annala, Kati K. Kivinummi, Gunilla Högnäs, Sergei Häyrynen, Tommi Rantapero, Virpi Kivinen, William B. Isaacs, Teemu T. Tolonen et al. · 2016 · Molecular Case Studies
  43. Translating premalignant biology to accelerate non-small-cell lung cancer interception
    Sarah A. Mazzilli, Zahraa Rahal, Maral J. Rouhani, Sam M. Janes, Humam N. Kadara, Steven M. Dubinett, Avrum E. Spira · 2025 · Nature reviews. Cancer
  44. Chromatin-regulating proteins as targets for cancer therapy
    Takahiro Oike, Hideaki Ogiwara, Napapat Amornwichet, Takashi Nakano, Takashi Kohno · 2014 · Journal of Radiation Research
  45. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma
    Jie Zhao, Chen Jiang, Hui Min Lin, Renan Jin, Jinghua Liu, Xiaolong Liu, Ning Meng, Xiujun Cai · 2015 · Pathology & Oncology Research
  46. The Molecular Pathology of Lung Cancer
    Lynette Marie Sholl · 2016 · Surgical pathology clinics
  47. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma
    Michael F. Sharpnack, Bin Chen, Dvir Aran, Idit Kosti, Douglas D. Sharpnack, David Paul Carbone, Parag Mallick, Kun Huang · 2017 · EBioMedicine
  48. Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
    Vanessa D. Jönsson, Collin M. Blakely, Luping Lin, Saurabh Asthana, Nikolai Matni, Victor R. Olivas, Evangelos Pazarentzos, Matthew A. Gubens, Boris C. Bastian, Barry S. Taylor et al. · 2017 · Scientific Reports
  49. EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates
    Daniel Sentana‐Lledo, Emmeline C. Academia, Hollis Viray, Deepa Rangachari, Susumu S. Kobayashi, Paul A. VanderLaan, Daniel Botelho Costa · 2023 · Translational Lung Cancer Research
  50. Genomic sequencing in cancer
    Musaffe Tuna, Christopher Ian Amos · 2012 · Cancer Letters
  51. Looking beyond drivers and passengers in cancer genome sequencing data
    Subhajyoti De, Shridar Ganesan · 2016 · Annals of Oncology
  52. Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors
    Miroslava Kretová, Tomas Selicky, Ingrid Čipáková, Luboš Čipák · 2023 · Life
  53. Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
    Joris van de Haar, Joanne M. Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert Frederik Smit, Lodewyk F.A. Wessels, Edwin P. J. G. Cuppen, Joachim G.J.V. Aerts, Emile E. Voest · 2024 · Clinical Cancer Research
  54. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target
    Maojian Chen, Shaoping Zhang, Fan Wang, Junyi He, Wei Jiang, Li Zhang · 2024 · Journal of Translational Medicine
  55. Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma
    Mingjun Gao, Mengmeng Wang, Siding Zhou, Jiaqi Hou, Wenbo He, Yusheng Shu, Xiaolin Wang · 2024 · Cancer Cell International
  56. Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
    Evgeny A. Moskalev, Robert Stöhr, Ralf J. Rieker, Simone Hebele, Florian Siegfried Fuchs, Horia Sı̂rbu, Sergey Mastitsky, Carsten Boltze, Helmut König, Abbas Agaimy et al. · 2013 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  57. Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis
    Li Tai Fang, Sharon Chih Lin Lee, Helen Choi, Hong Kwan Kim, Gregory Jew, Hio Chung Kang, Lin Chen, David M. Jablons, Il-Jin Kim · 2013 · International Journal of Oncology
  58. Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma
    Thomas K. Ni, Sean F. Landrette, Robert D. Bjornson, Marcus Bosenberg, Tian Xu · 2013 · Proceedings of the National Academy of Sciences
  59. Identification by FFPE RNA‐Seq of a new recurrent inversion leading to RBM10‐TFE3 fusion in renal cell carcinoma with subtle TFE3 break‐apart FISH pattern
    Pierre‐Alexandre Just, Franck Letourneur, Christelle Pouliquen, Florence Dome, Anne Audebourg, P Biquet, Michel Vidaud, Benoît Terris, Mathilde Sibony, Éric Pasmant · 2016 · Genes Chromosomes and Cancer
  60. Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
    Mohammad Alinoor Rahman, Farhana Nasrin, Sonali Bhattacharjee, Saikat Nandi · 2020 · Cancers
  61. A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients
    Rui Cheng, Lixing Xiao, Wenyang Zhou, Xiyun Jin, Zhaochun Xu, Chang Xu, Pingping Wang, Meng Luo, Mengyun Wang, Kexin Ma et al. · 2021 · Oncogene
  62. Aberrant RNA splicing and therapeutic opportunities in cancers
    Hirofumi Yamauchi, Kazuki Nishimura, Akihide Yoshimi · 2021 · Cancer Science
  63. The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells
    Napapat Amornwichet, Takahiro Oike, Atsushi Shibata, Chaitanya S. Nirodi, Hideaki Ogiwara, Haruhiko Makino, Yuka Kimura, Yuka Hirota, Mayu Isono, Yukari Yoshida et al. · 2015 · Scientific Reports
  64. Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma
    Liu, Yan, Li, Yuyang, Wang, Xiaoen, Liu, Feiyang, Gao, Peng, Quinn, Max M., Li, Fei, Merlino, Ashley A., Benes, Cyril, Liu, Qingsong et al. · 2017 · Cancer Research
  65. Genomic Approaches to DNA repair and Mutagenesis
    John J. Wyrick, Steven A. Roberts · 2015 · DNA Repair
  66. Distinct mutation accumulation rates among tissues determine the variation in cancer risk
    Dapeng Hao, Li Wang, Lijun Di · 2016 · Scientific Reports
  67. Characterization of germline mutations in familial lung cancer from the Chinese population
    Madiha Kanwal, Xiaojie Ding, Zhanshan Sam Ma, Lianwei Li, Ping Wang, Ying Chen, Yunchao Huang, Yi Cao · 2017 · Gene
  68. ZWINT is the next potential target for lung cancer therapy
    Fang Peng, Qiang Li, Shao-Qing Niu, Guo-Ping Shen, Ying Luo, Ming Chen, Yong Bao · 2019 · Journal of Cancer Research and Clinical Oncology
  69. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer
    Chai-Jin Lee, Hongryul Ahn, Dabin Jeong, Minwoo Pak, Ji Hwan Moon, Sun Kim · 2020 · BMC Medical Genomics
  70. High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study
    Eva‐Maria Talvitie, Heikki Vilhonen, Samu H. Kurki, Antti Karlsson, Katri J. Orte, Alhadi Almangush, Hesham Mohamed, Lassi Liljeroos, Yajuvinder Singh, Ilmo V.V. Leivo et al. · 2020 · Neoplasia
  71. TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
    Haining Li, Liping Guo, Zhigang Cai · 2022 · World Journal of Surgical Oncology
  72. Nascent alt-protein chemoproteomics reveals a pre-60S assembly checkpoint inhibitor
    Xiongwen Cao, Alexandra Khitun, Cecelia M. Harold, Carson J. Bryant, Shu-Jian Zheng, Susan J. Baserga, Sarah A. Slavoff · 2022 · Nature Chemical Biology
  73. Overexpression of human Argonaute2 inhibits cell and tumor growth
    Xiaoxiao Zhang, Paul R. Graves, Yan Zeng · 2012 · Biochimica et Biophysica Acta (BBA) - General Subjects
  74. Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
    Jin‐Woo Ahn, Han Sang Kim, Jung-Ki Yoon, Hoon Sik Jang, Soo Min Han, Sungho Eun, Hyo Sup Shim, Hyun Jung Kim, Dae Joon Kim, Jin Gu Lee et al. · 2014 · Genome Medicine
  75. A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation
    Chandani Warnasooriya, Eliezra Glasser, Callen F. Feeney, Kholiswa M. Laird, Jermaine L. Jenkins, Dmitri N. Ermolenko, Clara L. Kielkopf · 2020 · Nucleic Acids Research
  76. Understanding the dynamic design of the spliceosome
    Irene Beusch, Hiten D. Madhani · 2024 · Trends in Biochemical Sciences
  77. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations
    Sandy Chevrier, Laurent Arnould, François Ghiringhelli, Bruno P. Coudert, P. Fumoleau, Romain Boidot · 2014 · International Journal of Oncology
  78. Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles
    Bülent Arman Aksoy, Emek Demir, Özgün Babur, Weiqing Wang, Xiaohong Jing, Nikolaus D. Schultz, Chris Sander · 2014 · Bioinformatics
  79. Mechanisms of Resistance to Immune Checkpoint Antibodies
    Rodrigo Nalio Ramos, Eliane Piaggio, Emanuela Romano · 2017 · Handbook of experimental pharmacology
  80. Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer
    Maxim Noeparast, Philippe Giron, Sylvia De Brakeleer, Carolien Eggermont, Ulrike De Ridder, Erik Teugels, Jacques De Grève · 2018 · Oncotarget
  81. Functional role of RBM10 in lung adenocarcinoma proliferation
    Xiuna Sun, Mengqi Jia, Wei Sun, Feng Lu, Chundong Gu, Taihua Wu · 2018 · International Journal of Oncology
  82. Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
    Jian Carrot‐Zhang, Xiaotong Yao, Siddhartha H. K. Devarakonda, Aditya S. Deshpande, Jeffrey S. Damrauer, Tiago C. Silva, Christopher K. Wong, Hyo Young Choi, Ina Felau, A. Gordon Robertson et al. · 2021 · Cell Reports
  83. RNA-binding proteins of COSMIC importance in cancer
    Peter S. Choi, Andrei Thomas‐Tikhonenko · 2021 · Journal of Clinical Investigation
  84. Mutations of Chromatin Structure Regulating Genes in Human Malignancies
    Jian Chen, H. Franklin Herlong, John R. Stroehlein, Lopa Mishra · 2016 · Current Protein and Peptide Science
  85. Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients
    Ka Chen, Hongliang Liu, Zhensheng Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, Qingyi Wei · 2019 · International Journal of Cancer
  86. Alternative splicing in prostate cancer progression and therapeutic resistance
    Chitra Rawat, Hannelore V. Heemers · 2024 · Oncogene
  87. An emerging place for lung cancer genomics in 2013.
    Marissa G. Daniels, Rayleen Bowman, Ian A. Yang, Ramaswamy Govindan, Kwun Meng Fong · 2013 · Europe PMC (PubMed Central)
  88. The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer
    Marzena Anna Lewandowska, Karol Czubak, Katarzyna Klonowska, Wojciech Jóźwicki, Janusz Kowalewski, Piotr Kozłowski · 2015 · PLoS ONE
  89. Gene Silencing Associated with SWI/SNF Complex Loss during NSCLC Development
    Shujie Song, Vonn Walter, Mehmet Karaca, Ying Li, Christopher S. Bartlett, Dominic J. Smiraglia, Daniel Serber, Christopher D. Sproul, Christoph Plass, Jiren Zhang et al. · 2014 · Molecular Cancer Research
  90. The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases
    Leora Witkowski, Nancy Donini, R. Byler Dann, James A. Knost, Steffen Albrecht, Andrew Berchuck, Wilson Glenn McCluggage, Martin Hasselblatt, William David Foulkes · 2016 · Familial Cancer
  91. Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins
    Zeev Waks, Omer Weissbrod, Boaz Carmeli, Raquel Norel, Filippo Utro, Yaara Goldschmidt · 2016 · Scientific Reports
  92. miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4
    Xuelian Xiao, Daheng Yang, Xue Qian Gong, Dongping Mo, Shiyang Pan, Jian Xu · 2018 · Oncotarget
  93. Oncogene-addicted non-small cell lung cancer and immunotherapy
    Georgios Tsakonas, Simon Ekman · 2018 · Journal of Thoracic Disease
  94. Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer
    Rongqiang Yang, Steven W. Li, Zirong Chen, Xin Zhou, Wei Min NI, Dongtao Fu, Jianrong Lu, Frederic J. Kaye, Lizi Wu · 2018 · JNCI Journal of the National Cancer Institute
  95. Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers
    Zhaoqing Sun, Bo Yan · 2019 · Clinical Genetics
  96. New Frontiers for Molecular Pathology
    Joanna J. Domagala-Kulawik · 2019 · Frontiers in Medicine
  97. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients
    Yuyu Feng, Conghui Liu, Xue Yang, Yuanyuan Chen, Yuli Wang, Xiong-Zhi Wu · 2019 · Gene
  98. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer
    Ivana Heřmanová, Patricia Zúñiga-García, Alfredo Caro‐Maldonado, Sonia Fernández‐Ruiz, Fernando Salvador, Natalia Martín-Martín, Amaia Zabala‐Letona, Marc Núnez-Ollé, Verónica Torrano, Laura Camacho et al. · 2020 · The Journal of Experimental Medicine
  99. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors
    Zhouwei Zhang, Netta Mäkinen, Yosuke Kasai, Grace Kim, Begoña Diosdado, Eric K. Nakakura, Matthew M. Meyerson · 2020 · Genes Chromosomes and Cancer
  100. Non-small-cell lung cancer
    Hendrik J. Agteresch, Pieter C, Ate van der Gaast, J.H.P. Wilson · 2015 · Nature Reviews Disease Primers